Manhattan Pharmaceuticals
New York, US
Founders & leadership
SP
Sean PowerExecutive
MW
Michael WeissExecutive
Board
NH
Neil HerskowitzBoard director
Reported raises · per SEC filings
Form D private placements$36.1M disclosed across 2 rounds · 2011
▶$11.1MraisedMar 2012 · PharmaceuticalsRule 506(b)
▶$11.1MraisedMar 2012 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL WEISSExecutive Officer, Director
- SEAN POWERExecutive Officer
- NEIL HERSKOWITZDirector
- Offering amount
- $25M
- Amount sold
- $11.1M
- Minimum investment
- $50K
- Sales commissions
- $25M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
▶$25MraisedFeb 2012 · 416 investors · PharmaceuticalsRule 506(b)
▶$25MraisedFeb 2012 · 416 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sean PowerExecutive Officer
- Neil HerskowitzDirector
- Michael WeissExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- Minimum investment
- $50K
- Sales commissions
- $2.5M
- Proceeds to insiders
- $2.4M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Manhattan Pharmaceuticals raised?
- Manhattan Pharmaceuticals has disclosed $36.1M raised across 2 rounds.
- Where is Manhattan Pharmaceuticals headquartered?
- Manhattan Pharmaceuticals is headquartered in New York, US.